Skip to content

Evaluation of Dhanwantar Ghritam in Guda Arsha

Clinical evaluation of Dhanwantar Ghritam Matra Basti in Guda Arsha Haemorrhoids - ARSH

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074449
Enrollment
30
Registered
2024-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

None listed

Sponsors

Tejas Mishra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient’s age ranging from 18 to 60 years. 2.The patients having complaints of I and II degree internal Hemorrhoids will be taken for the study after screening. 3.Patients willing to undergo trial and ready to give informed and written consent.

Exclusion criteria

Exclusion criteria: 1.Patients below the age of 18 years and above the age of 60 years. 2.Third degree prolapsed internal and external Haemorrhoids. 3.Pregnancy. 4.Congenital deformity. 5.Known case of Carcinoma and Tuberculosis. 6.Rectal prolapsed. 7.Patients suffering from other systemic diseases such as HIV, known case of Hepatitis B, Ulcerative colitis, Crohn’s disease, Cirrhosis of liver and Carcinoma of rectum will be excluded from this study. 8.Patient with uncontrolled DM and HTN. 9.External thrombosed Haemorrhoids. 10.The associated condition like Fistula-in-ano, Fissure-in-ano will be excluded from this study.

Design outcomes

Primary

MeasureTime frame
To help regress the growth of hemorrhoids further into 3rd and 4th degree.Timepoint: 28 days

Secondary

MeasureTime frame
Provide a alternative and safe treatment for hemorrhoids.Timepoint: 18 months

Countries

India

Contacts

Public ContactTejas Mishra

Quadra Institute of Ayurveda and Hospital

deardrsaurabh@gmail.com9717944844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026